PharmaCyte Biotech, Inc. — Director's Dealing 2024

Jul 17, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PharmaCyte Biotech, Inc. (PMCB)
CIK: 0001157075
Period of Report: 2024-04-30

Reporting Person: SCHECHTER JONATHAN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-30	Stock Option (Right to Buy)	$2.12	A	38009	Acquired	2034-04-30	Common Stock (38009)	Direct

Footnotes

F1: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter.